A pharmaceutical composition, comprising a polyprenol as an active ingredient, as well as suitable for use therein polyprenolen.

• 1. 聚环戊二烯多酚和聚氰酸酯聚环戊二烯多酚化合物 [P] . 中国专利： CN102971282B . 2015.11.25
• 2. 聚环戊二烯多酚和聚氰酸酯聚环戊二烯多酚化合物 [P] . 中国专利： CN105175988A . 2015-12-23
• 3. pharmaceutical preparation, a polyprenol as active ingredient, and suitable for application in polyprenolen. [P] . NL194300B . 2001-08-01

  机译： 药物制剂，以聚戊二烯为有效成分，适用于聚戊烯醇。

• 4. PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IL-4 AS ACTIVE INGREDIENT AND SUITABLE FOR TREATING THICK TUMOURS [P] . HUT63769A . 1993-10-28

  机译： 生产包含IL-4作为有效成分的药物组合物的方法，适合治疗厚瘤

• 5. PROCESS FOR PRODUCING PEPTIDE DERIVATIVES SUITABLE FOR TREATING GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AS ACTIVE INGREDIENT [P] . HUT61322A . 1992-12-28

  机译： 制备适用于治疗与活性成分相同的青光眼和药物成分的肽衍生物的方法

• 1. Simultaneous and Trace Level Quantification of Five Potential Genotoxic Impurities in Ranolazine Active Pharmaceutical Ingredient Using LC-MS/MS [J] . Kartheek Srinivas Chidella, Vijaya Bharathi Dasari, Jayashree Anireddy 美国分析化学（英文） . 2021,第001期
• 2. Development of a rapid GC-FID method to simultaneously determine triethylamine,diisopropylamine,and 1,1,3,3-tetramethylguanidine residues in an active pharmaceutical ingredient [J] . Minshan Shou, Haixiao Qiu 药物分析学报（英文） . 2021,第002期
• 3. Multiple Emulsions Able to Be Used for Oral Administration of Active Pharmaceutical Ingredients: Physico-Chemical Parameters Study of Different Phases [J] . Louis Augustin Diaga Diouf, Alphonse Rodrigue Djiboune, Mamadou Soumboundou, 现代物理（英文） . 2020,第010期
• 4. Potential of THz-TDS for Crystallinity State Inspection of Active Pharmaceutical Ingredients in SmartFilms® [C] . Jan Ornik, Daniel Knoth, Cornelia M. Keck, International Conference on Infrared, Millimeter, and Terahertz Waves . 2020
• 5. Improved Characterization of Pure and Formulated Active Pharmaceutical Ingredients by Fast Magic Angle Spinning Solid-State NMR Spectroscopy [D] . Wijesekara, Anuradha V. 2020
• 6. A Pediatrics Utilization Study in The Netherlands to Identify Active Pharmaceutical Ingredients Suitable for Inkjet Printing on Orodispersible Films [O] . J. Carolina Visser, Lisa Wibier, Olga Kiefer, 2020
• 7. Compositional effect of complex biorelevant media on the crystallization kinetics of an active pharmaceutical ingredient [O] . Jennifer Lu, James D. Ormes, Michael Lowinger, 2017

• 1. Simultaneous Determination of N-Acetyl Cysteine and Taurine by HPTLC Method in Active Pharmaceutical Ingredient and Pharmaceutical Dosage Form [J] . A. R. Magesh ,Magharla Dasaratha Dhanaraju . 美国分析化学（英文） . 2017,第11期
• 2. Analysis of the Current Situation of Active Pharmaceutical Ingredient (API) Export in China [J] . Kong Deqiang1 ,Dong Li1 . 亚洲社会药学 . 2019,第003期
• 3. 聚丁二烯型聚氨酯/聚（甲基丙烯甲酯—共—二甲基丙烯酸乙二醇酯）互穿聚合物网络的研究 [C] . 吴波 ,贾德民 ,王孟钟 . 中国化学会第五届低聚物化学讨论会 . 1986
• 4. 聚己内酯-聚乙二醇及聚（己内酯/乙交酯）-聚乙二醇嵌段共聚物胶束药物缓释研究 [A] . 孙祥科 . 2018